[On immunopathological phenomena in bullous pemphigoid].

W. Leszczynski,G. Bossi,L. Muscardin

1969-10-01

Abstract:

What problem does this paper attempt to address?

Fusobacterium Nucleatum Subspecies Animalis Influences Proinflammatory Cytokine Expression and Monocyte Activation in Human Colorectal Tumors.

Xiangcang Ye,Rui Wang,Rajat Bhattacharya,Delphine R. Boulbes,Fan,Ling Xia,Adoni Harish,Nadim J. Ajami,Matthew C. Wong,Daniel P. Smith,Joseph F. Petrosino,Susan Venable,Wei Qiao,Veera Baladandayuthapani,Dipen Maru,Lee M. Ellis

DOI: https://doi.org/10.1158/1940-6207.capr-16-0178

IF: 11.2

2017-01-01

Cancer Research

Abstract:AbstractChronic infection and associated inflammation have long been suspected to promote human carcinogenesis. Recently, certain gut bacteria, including some in the Fusobacterium genus, have been implicated in playing a role in human colorectal cancer development. However, the Fusobacterium species and subspecies involved and their oncogenic mechanisms remain to be determined. We sought to identify the specific Fusobacterium spp. and ssp. in clinical colorectal cancer specimens by targeted sequencing of Fusobacterium 16S ribosomal RNA gene. Five Fusobacterium spp. were identified in clinical colorectal cancer specimens. Additional analyses confirmed that Fusobacterium nucleatum ssp. animalis was the most prevalent F. nucleatum subspecies in human colorectal cancers. We also assessed inflammatory cytokines in colorectal cancer specimens using immunoassays and found that expression of the cytokines IL17A and TNFα was markedly increased but IL21 decreased in the colorectal tumors. Furthermore, the chemokine (C-C motif) ligand 20 was differentially expressed in colorectal tumors at all stages. In in vitro co-culture assays, F. nucleatum ssp. animalis induced CCL20 protein expression in colorectal cancer cells and monocytes. It also stimulated the monocyte/macrophage activation and migration. Our observations suggested that infection with F. nucleatum ssp. animalis in colorectal tissue could induce inflammatory response and promote colorectal cancer development. Further studies are warranted to determine if F. nucleatum ssp. animalis could be a novel target for colorectal cancer prevention and treatment. Cancer Prev Res; 10(7); 398–409. ©2017 AACR.
The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesis

Lu Zhang,Xiao-Xu Leng,Jianxun Qi,Ni Wang,Ji-Xuan Han,Zhi-Hang Tao,Zi-Yan Zhuang,Yimeng Ren,Yi-Le Xie,Shan-Shan Jiang,Jia-Lu Li,Huimin Chen,Cheng-Bei Zhou,Yun Cui,Xiaoyu Chen,Zheng Wang,Zi-Zhen Zhang,Jie Hong,Hao-Yan Chen,Weihong Jiang,Ying-Xuan Chen,Xin Zhao,Jun Yu,Jing-Yuan Fang

DOI: https://doi.org/10.1038/s41564-024-01784-w

IF: 28.3

2024-08-23

Nature Microbiology

Abstract:Fusobacterium nucleatum can bind to host cells and potentiate intestinal tumorigenesis. Here we used a genome-wide screen to identify an adhesin, RadD, which facilitates the attachment of F. nucleatum to colorectal cancer (CRC) cells in vitro. RadD directly binds to CD147, a receptor overexpressed on CRC cell surfaces, which initiated a PI3K–AKT–NF–κB–MMP9 cascade, subsequently enhancing tumorigenesis in mice. Clinical specimen analysis showed that elevated radD gene levels in CRC tissues correlated positively with activated oncogenic signalling and poor patient outcomes. Finally, blockade of the interaction between RadD and CD147 in mice effectively impaired F. nucleatum attachment and attenuated F. nucleatum -induced oncogenic response. Together, our study provides insights into an oncogenic mechanism driven by F. nucleatum RadD and suggests that the RadD–CD147 interaction could be a potential therapeutic target for CRC.

microbiology
Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7

Shujie Chen,Tingting Su,Ying Zhang,Allen Lee,Jiamin He,Qiwei Ge,Lan Wang,Jianmin Si,Wei Zhuo,Liangjing Wang

DOI: https://doi.org/10.1080/19490976.2019.1695494

IF: 12.2

2020-01-01

Gut Microbes

Abstract:The enrichment of Fusobacterium nucleatum (Fn) has been identified in CRC patients and associated with worse outcomes. However, whether Fn was involved in the metastasis of CRC was not well determined. Here, we found that the abundance of Fn was significantly increased in CRC patients with lymph nodes metastasis. To further clarify the role of Fn in CRC metastasis, we performed transwell and wound healing assays after incubating CRC cell lines with or without Fn and injected Fn-treated or untreated CRC cells into nude mice via tail vein. The results indicated that Fn infection promoted CRC cells migration in vitro, as well as lung metastasis in vivo. Interestingly, colonization of Fn was detected in metastatic lung lesions of nude mice by fluorescence in situ hybridization. Mechanistically, RNA sequencing and validation study revealed that Fn significantly upregulated the expression of long non-coding RNA Keratin7-antisense (KRT7-AS) and Keratin7 (KRT7) in CRC cells. Importantly, Fn-induced CRC lung metastasis was attenuated by the depletion of KRT7-AS. In addition, KRT7-AS facilitated CRC cells migration by upregulating KRT7. Subsequently, we found that NF-kappa B signaling pathway was involved in the upregulation of KRT7-AS upon Fn infection. In conclusion, Fn infection upregulated KRT7-AS/KRT7 by activating NF-kappa B pathway, which promoted CRC cell migration in vitro and metastasis in vivo.
Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS /KRT7.

Shujie Chen,Tingting Su,Ying Zhang,Allen Lee,Jiamin He,Qiwei Ge,Lan Wang,Jianmin Si,Wei Zhuo,Liangjing Wang

DOI: https://doi.org/10.1080/19490976.2019.1695494

IF: 12.2

2020-01-01

Gut Microbes

Abstract:The enrichment of Fusobacterium nucleatum (Fn) has been identified in CRC patients and associated with worse outcomes. However, whether Fn was involved in the metastasis of CRC was not well determined. Here, we found that the abundance of Fn was significantly increased in CRC patients with lymph nodes metastasis. To further clarify the role of Fn in CRC metastasis, we performed transwell and wound healing assays after incubating CRC cell lines with or without Fn and injected Fn-treated or untreated CRC cells into nude mice via tail vein. The results indicated that Fn infection promoted CRC cells migration in vitro, as well as lung metastasis in vivo. Interestingly, colonization of Fn was detected in metastatic lung lesions of nude mice by fluorescence in situ hybridization. Mechanistically, RNA sequencing and validation study revealed that Fn significantly upregulated the expression of long non-coding RNA Keratin7-antisense (KRT7-AS) and Keratin7 (KRT7) in CRC cells. Importantly, Fn-induced CRC lung metastasis was attenuated by the depletion of KRT7-AS. In addition, KRT7-AS facilitated CRC cells migration by upregulating KRT7. Subsequently, we found that NF-kappa B signaling pathway was involved in the upregulation of KRT7-AS upon Fn infection. In conclusion, Fn infection upregulated KRT7-AS/KRT7 by activating NF-kappa B pathway, which promoted CRC cell migration in vitro and metastasis in vivo.
Adhesin RadD: the secret weapon of Fusobacterium nucleatum

Dingjiacheng Jia,Shujie Chen

DOI: https://doi.org/10.1080/19490976.2024.2426617

IF: 12.2

2024-11-11

Gut Microbes

Abstract:Fusobacterium nucleatum can promote colorectal cancer (CRC) development through a variety of virulence proteins. Zhang et al. recently identified an adhesin RadD, for Fusobacterium nucleatum adhesion to CRC. Targeting the interaction between RadD and CD147 will provide a new strategy for CRC treatment. This Commentary and View not only summarizes the research highlights but also discusses the possibility of targeted clearance of Fusobacterium nucleatum in clinical applications.

gastroenterology & hepatology,microbiology
Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation

K. Mikami,K. Akakura,K. Takei,T. Ueda,Ken’ichi Mizoguchi,M. Noda,M. Miyake,Haruo Ito

DOI: https://doi.org/10.1046/j.1442-2042.2003.00634.x

2003-06-01

International Journal of Urology

Abstract:Aim: Urinary concentration of oxalate is considered an important factor in the formation of renal stones. Dietary oxalate is a major contributor to urinary oxalate excretion in most individuals. Furthermore, oxalate degrading bacteria have been isolated from human feces. We investigated the significance of oxalate degrading bacteria for urinary oxalate excretion and urinary stone formation.
Antibacterial Fusobacterium Nucleatum‐Mimicking Nanomedicine to Selectively Eliminate Tumor‐colonized Bacteria And Enhance Immunotherapy Against Colorectal Cancer

Linfu Chen,Rui Zhao,Jingjing Shen,Nanhui Liu,Zixuan Zheng,Yu Miao,Jiafei Zhu,Lin Zhang,Yingyao Wang,Huapan Fang,Jun Zhou,Maoyi Li,Yang Yang,Zhuang Liu,Qian Chen

DOI: https://doi.org/10.1002/adma.202306281

IF: 29.4

2023-09-20

Advanced Materials

Abstract:Clinical evidence has indicated that tumor‐colonizing bacteria would be closely related to the tumor development and therapeutic responses. Selectively eliminating bacteria within tumors may be an attractive approach to enhance cancer treatment without additional side effects. Herein, we found that owing to the high affinity between the membrane protein Fap‐2 on Fusobacterium nucleatum (F. nucleatum) and D‐galactose‐β (1‐3)‐N‐acetyl‐D‐galactosamine (Gal‐GalNAc) overexpressed on colorectal tumor cells, F. nucleatum would colonize in colorectal tumors, as evidenced by both clinical samples and animal tumor models. Notably, F. nucleatum colonized in colorectal tumors would lead to immunosuppressive tumor microenvironment, greatly reducing their responses to immune checkpoint blockade (ICB) therapy. Inspired by this finding, we designed a F. nucleatum‐mimetic nanomedicine by fusing F. nucleatum cytoplasmic membrane (FM) with Colistin loaded liposomes to achieve selectively killing tumor‐colonizing F. nucleatum without affecting gut microbes. As the results, the therapeutic responses of F. nucleatum‐colonized tumors to ICB therapies could be successfully restored, as demonstrated in F. nucleatum‐infected subcutaneous CT‐26 tumor model, chemical‐induced spontaneous colorectal cancer models and MC‐38 tumor model. In summary, our work presented a F. nucleatum‐Mimicking nanomedicine which could selectively eliminate tumor‐colonized bacteria, promising for enhancing the responses of cancer immunotherapy against F. nucleatum‐colonized colorectal cancer. This article is protected by copyright. All rights reserved

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology
Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1/TIFA axis activation

Camille Martin-Gallausiaux,Laurène Salesse,Diego Garcia-Weber,Ludovica Marinelli,Fabienne Beguet-Crespel,Vincent Brochard,Camille Le Gléau,Alexandre Jamet,Joël Doré,Hervé M. Blottière,Cécile Arrieumerlou,Nicolas Lapaque

DOI: https://doi.org/10.1080/19490976.2023.2295384

IF: 12.2

2023-12-23

Gut Microbes

Abstract:The anaerobic bacterium Fusobacterium nucleatum is significantly associated with human colorectal cancer (CRC) and is considered a significant contributor to the disease. The mechanisms underlying the promotion of intestinal tumor formation by F. nucleatum have only been partially uncovered. Here, we showed that F. nucleatum releases a metabolite into the microenvironment that strongly activates NF-κB in intestinal epithelial cells via the ALPK1/TIFA/TRAF6 pathway. Furthermore, we showed that the released molecule had the biological characteristics of ADP-heptose. We observed that F. nucleatum induction of this pathway increased the expression of the inflammatory cytokine IL-8 and two anti-apoptotic genes known to be implicated in CRC, BIRC3 and TNFAIP3 . Finally, it promoted the survival of CRC cells and reduced 5-fluorouracil chemosensitivity in vitro . Taken together, our results emphasize the importance of the ALPK1/TIFA pathway in Fusobacterium induced-CRC pathogenesis, and identify the role of ADP-H in this process.

gastroenterology & hepatology,microbiology
Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β‐catenin modulator Annexin A1

Mara Roxana Rubinstein,Jung Eun Baik,Stephen M Lagana,Richard P Han,William J Raab,Debashis Sahoo,Piero Dalerba,Timothy C Wang,Yiping W Han

DOI: https://doi.org/10.15252/embr.201847638

IF: 9.071

2019-03-04

EMBO Reports

Abstract:Fusobacterium nucleatum, a Gram-negative oral anaerobe, is a significant contributor to colorectal cancer. Using an in vitro cancer progression model, we discover that F. nucleatum stimulates the growth of colorectal cancer cells without affecting the pre-cancerous adenoma cells. Annexin A1, a previously unrecognized modulator of Wnt/β-catenin signaling, is a key component through which F. nucleatum exerts its stimulatory effect. Annexin A1 is specifically expressed in proliferating colorectal cancer cells and involved in activation of Cyclin D1. Its expression level in colon cancer is a predictor of poor prognosis independent of cancer stage, grade, age, and sex. The FadA adhesin from F. nucleatum up-regulates Annexin A1 expression through E-cadherin. A positive feedback loop between FadA and Annexin A1 is identified in the cancerous cells, absent in the non-cancerous cells. We therefore propose a "two-hit" model in colorectal carcinogenesis, with somatic mutation(s) serving as the first hit, and F. nucleatum as the second hit exacerbating cancer progression after benign cells become cancerous. This model extends the "adenoma-carcinoma" model and identifies microbes such as F. nucleatum as cancer "facilitators".

cell biology,biochemistry & molecular biology
Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer

Yaohui Gao,Dexi Bi,Ruting Xie,Man Li,Jing Guo,Hu Liu,Xianling Guo,Juemin Fang,Tingting Ding,Huiyuan Zhu,Yuan Cao,Meichun Xing,Jiayi Zheng,Qing Xu,Qian Xu,Qing Wei,Huanlong Qin

DOI: https://doi.org/10.1038/s41392-021-00795-x

IF: 39.3

2021-11-19

Signal Transduction and Targeted Therapy

Abstract:Abstract Given that only a subset of patients with colorectal cancer (CRC) benefit from immune checkpoint therapy, efforts are ongoing to identify markers that predict immunotherapeutic response. Increasing evidence suggests that microbes influence the efficacy of cancer therapies. Fusobacterium nucleatum induces different immune responses in CRC with different microsatellite-instability (MSI) statuses. Here, we investigated the effect of F. nucleatum on anti-PD-L1 therapy in CRC. We found that high F. nucleatum levels correlate with improved therapeutic responses to PD-1 blockade in patients with CRC. Additionally, F. nucleatum enhanced the antitumor effects of PD-L1 blockade on CRC in mice and prolonged survival. Combining F. nucleatum supplementation with immunotherapy rescued the therapeutic effects of PD-L1 blockade. Furthermore, F. nucleatum induced PD-L1 expression by activating STING signaling and increased the accumulation of interferon-gamma (IFN-γ) + CD8 + tumor-infiltrating lymphocytes (TILs) during treatment with PD-L1 blockade, thereby augmenting tumor sensitivity to PD-L1 blockade. Finally, patient-derived organoid models demonstrated that increased F. nucleatum levels correlated with an improved therapeutic response to PD-L1 blockade. These findings suggest that F. nucleatum may modulate immune checkpoint therapy for CRC.

biochemistry & molecular biology,cell biology
Fusobacterium nucleatum induces a tumor microenvironment with diminished adaptive immunity against colorectal cancers

Han Sang Kim,Chang Gon Kim,Won Kyu Kim,Kyung-A Kim,Jinseon Yoo,Byung Soh Min,Soonmyung Paik,Sang Joon Shin,Hyukmin Lee,Kyungwon Lee,Hoguen Kim,Eui-Cheol Shin,Tae-Min Kim,Joong Bae Ahn

DOI: https://doi.org/10.3389/fcimb.2023.1101291

2023-03-07

Abstract:Background & aims: Fusobacterium nucleatum (FN) plays a pivotal role in the development and progression of colorectal cancer by modulating antitumor immune responses. However, the impact of FN on immune regulation in the tumor microenvironment has not been fully elucidated. Methods: The abundance of FN was measured in 99 stage III CRC tumor tissues using quantitative polymerase chain reaction. Gene expression profiles were assessed and annotated using consensus molecular subtypes (CMS), Gene Ontology (GO) analysis, and deconvolution of individual immune cell types in the context of FN abundance. Immune profiling for tumor infiltrating T cells isolated from human tumor tissues was analyzed using flow cytometry. Ex vivo tumor-infiltrating T cells were stimulated in the presence or absence of FN to determine the direct effects of FN on immune cell phenotypes. Results: Gene expression profiles, CMS composition, abundance of immune cell subtypes, and survival outcomes differed depending on FN infection. We found that FN infection was associated with poorer disease-free survival and overall survival in stage III CRC patients. FN infection was associated with T cell depletion and enrichment of exhausted CD8+ and FoxP3+ regulatory T cells in the tumor microenvironment. The presence of FN in tumors was correlated with a suppressive tumor microenvironment in a T cell-dependent manner. Conclusion: FN enhanced the suppressive immune microenvironment with high depletion of CD8+ T cells and enrichment of FoxP3+ regulatory T cells in human colorectal cancer cases. Our findings suggest a potential association for FN in adaptive immunity, with biological and prognostic implications.
Impact of Fusobacterium nucleatum in the gastrointestinal tract on natural killer cells

Yeon Ji Kim,Bu Kyung Kim,Seun Ja Park,Jae Hyun Kim

DOI: https://doi.org/10.3748/wjg.v27.i29.4879

IF: 5.374

2021-08-07

World Journal of Gastroenterology

Abstract:Gut microbial dysbiosis contributes to the development and progression of colorectal cancer (CRC). Natural killer (NK) cells are involved in early defense mechanisms to kill infective pathogens and tumor cells by releasing chemokines and cytokines. To better understand the relationship between the gut microbiome and CRC, it was hypothesized here that a high abundance of () in the gastrointestinal tract could cause reduced NK cell activity.To identify associations between gastrointestinal tract levels and NK cell activity.experiments were performed on NK cells treated with and to identify the effects of gut microbiome species on NK cells. Following 24 and 48 h of treatment, NK cell counts were measured. In parallel studies, C57BL/6 mice were given broad-spectrum antibiotics in their drinking water to reduce resident gut flora. After 3 wk, the mice received the various bacterial species or phosphate-buffered saline (PBS) oral gavage every 2 d for 6 wk. At the study end, blood samples were acquired to perform NK cell activity assessment and cytokine analysis. Intestinal tissues were collected and analyzed immunohistochemistry (IHC).The data show that after 3 wk of broad-spectrum antibiotic treatment, levels of total bacteria and were markedly decreased in mice. Gavage of significantly decreased NK cell activity relative to the activities of cells from mice treated with antibiotics only and PBS. The administration of decreased the proportion of NK46 cells based on IHC staining and increased the production of interleukin-1β and tumor necrosis factor-α.High levels of in the gastrointestinal tract reduced NK cell activity in mice, and the decrease in NK cell activity might be affected by increased pro-inflammatory cytokines after treatment

gastroenterology & hepatology
Cell cycle‐related proteins: a flow cytofluorometric study in human tumors

M. Danova,A. Riccardi,M. Giordano,M. Girino,G. Mazzini,L. Dezza,E. Ascari

DOI: https://doi.org/10.1016/0248-4900(88)90089-5

Biology of the Cell

Abstract:
Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15

Huiyuan Zhu,Man Li,Dexi Bi,Huiqiong Yang,Yaohui Gao,Feifei Song,Jiayi Zheng,Ruting Xie,Youhua Zhang,Hu Liu,Xuebing Yan,Cheng Kong,Yefei Zhu,Qian Xu,Qing Wei,Huanlong Qin

DOI: https://doi.org/10.1038/s41467-024-45572-w

IF: 16.6

2024-02-25

Nature Communications

Abstract:Fusobacterium nucleatum ( F. nucleatum ) promotes intestinal tumor growth and its relative abundance varies greatly among patients with CRC, suggesting the presence of unknown, individual-specific effectors in F. nucleatum -dependent carcinogenesis. Here, we identify that F. nucleatum is enriched preferentially in KRAS p.G12D mutant CRC tumor tissues and contributes to colorectal tumorigenesis in Villin-Cre/Kras G12D+/- mice. Additionally, Parabacteroides distasonis ( P. distasonis ) competes with F. nucleatum in the G12D mouse model and human CRC tissues with the KRAS mutation. Orally gavaged P. distasonis in mice alleviates the F. nucleatum -dependent CRC progression. F. nucleatum invades intestinal epithelial cells and binds to DHX15, a protein of RNA helicase family expressed on CRC tumor cells, mechanistically involving ERK/STAT3 signaling. Knock out of Dhx15 in Villin-Cre/Kras G12D+/- mice attenuates the CRC phenotype. These findings reveal that the oncogenic effect of F. nucleatum depends on somatic genetics and gut microbial ecology and indicate that personalized modulation of the gut microbiota may provide a more targeted strategy for CRC treatment.

multidisciplinary sciences
Therapeutic Target Identification and Inhibitor Screening against Riboflavin Synthase of Colorectal Cancer Associated Fusobacterium nucleatum

Khurshid Jalal,Kanwal Khan,Zarrin Basharat,Ahmad Alzamami,Norah A. Alturki,Mutaib M. Mashraqi

DOI: https://doi.org/10.3390/cancers14246260

2022-12-20

Cancers

Abstract:Colorectal cancer (CRC) ranks third among all cancers in terms of prevalence. There is growing evidence that gut microbiota has a role in the development of colorectal cancer. Fusobacterium nucleatum is overrepresented in the gastrointestinal tract and tumor microenvironment of patients with CRC. This suggests the role of F. nucleatum as a potential risk factor in the development of CRC. Hence, we aimed to explore whole genomes of F. nucleatum strains related to CRC to predict potential therapeutic markers through a pan-genome integrated subtractive genomics approach. In the current study, we identified 538 proteins as essential for F. nucleatum survival, 209 non-homologous to a human host, and 12 as drug targets. Eventually, riboflavin synthase (RiS) was selected as a therapeutic target for further processing. Three different inhibitor libraries of lead-like natural products, i.e., cyanobactins (n = 237), streptomycins (n = 607), and marine bacterial secondary metabolites (n = 1226) were screened against it. After the structure-based study, three compounds, i.e., CMNPD3609 (−7.63) > Malyngamide V (−7.03) > ZINC06804365 (−7.01) were prioritized as potential inhibitors of F. nucleatum. Additionally, the stability and flexibility of these compounds bound to RiS were determined via a molecular dynamics simulation of 50 ns. Results revealed the stability of these compounds within the binding pocket, after 5 ns. ADMET profiling showed compounds as drug-like, non-permeable to the blood brain barrier, non-toxic, and HIA permeable. Pan-genomics mediated drug target identification and the virtual screening of inhibitors is the preliminary step towards inhibition of this pathogenic oncobacterium and we suggest mouse model experiments to validate our findings.

oncology
Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner

Barath Udayasuryan,Zirui Zhou,Raffae N. Ahmad,Polina Sobol,Chengyu Deng,Tam T. D. Nguyen,Shivanie Kodikalla,Ryan Morrison,Ishan Goswami,Daniel J. Slade,Scott S. Verbridge,Chang Lu

DOI: https://doi.org/10.1038/s42003-024-06201-w

IF: 6.548

2024-05-10

Communications Biology

Abstract:Fusobacterium nucleatum , a gram-negative oral bacterium, has been consistently validated as a strong contributor to the progression of several types of cancer, including colorectal (CRC) and pancreatic cancer. While previous in vitro studies have shown that intracellular F. nucleatum enhances malignant phenotypes such as cell migration, the dependence of this regulation on features of the tumor microenvironment (TME) such as oxygen levels are wholly uncharacterized. Here we examine the influence of hypoxia in facilitating F. nucleatum invasion and its effects on host responses focusing on changes in the global epigenome and transcriptome. Using a multiomic approach, we analyze epigenomic alterations of H3K27ac and global transcriptomic alterations sustained within a hypoxia and normoxia conditioned CRC cell line HCT116 at 24 h following initial infection with F. nucleatum . Our findings reveal that intracellular F. nucleatum activates signaling pathways and biological processes in host cells similar to those induced upon hypoxia conditioning in the absence of infection. Furthermore, we show that a hypoxic TME favors F. nucleatum invasion and persistence and therefore infection under hypoxia may amplify malignant transformation by exacerbating the effects induced by hypoxia alone. These results motivate future studies to investigate host-microbe interactions in tumor tissue relevant conditions that more accurately define parameters for targeted cancer therapies.

biology
Transcription Factor E2F7 Hampers the Killing Effect of NK Cells against Colorectal Cancer Cells via Activating RAD18 Transcription

Bingdong Jiang,Binghua Yan,Hengjin Yang,He Geng,Peng Li

DOI: https://doi.org/10.4014/jmb.2308.08026

2023-11-17

Journal of Microbiology and Biotechnology

Abstract:As a pivotal defensive line against multitudinous malignant tumors, natural killer (NK) cells exist in the tumor microenvironment (TME). RAD18 E3 Ubiquitin Protein Ligase (RAD18) has been reported to foster the malignant progression of multiple cancers, but its effect on NK function has not been mined. Here, the study was designed to mine the mechanism by which RAD18 regulates the killing effect of NK cells on colorectal cancer (CRC) cells. Expression of E2F Transcription Factor 7 (E2F7) and RAD18 in CRC tissues, their correlation, binding sites, and RAD18 enrichment pathway were analyzed by bioinformatics. Expression of E2F7 and RAD18 in cells was assayed by qRT-PCR and western blot. Dual-luciferase assay and chromatin immunoprecipitation (ChIP) assay verified the regulatory relationship between E2F7 and RAD18. CCK-8 assay was utilized to assay cell viability, colony formation assay to detect cell proliferation, lactate dehydrogenase (LDH) test to assay NK cell cytotoxicity, ELISA to assay levels of granulocyte-macrophage colony-stimulating factor (GM-CSF), tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ), and immunofluorescence to detect expression of toxic molecules perforin and granzyme B. High expression of RAD18 and E2F7 was found in CRC tissues and cells. Silencing RAD18 could hamper the proliferation of CRC cells, foster viability and cytotoxicity of NK cells, and increase the secretion of GM-CSF, TNF-α, IFN-γ as well as the expression of perforin and granzyme B. Additionally, ChIP and dual-luciferase reporter assay ascertained the binding relationship between RAD18 promoter region and E2F7. E2F7 could activate the transcription of RAD18, and silencing RAD18 reversed the inhibitory effect of E2F7 overexpression on NK cell killing. This work clarified the inhibitory effect of the E2F7/RAD18 axis on NK cell killing in CRC, and proffered a new direction for immunotherapy of CRC in targeted immune microenvironment.

biotechnology & applied microbiology,microbiology
Modulation of Siglec-7 Signaling Via In Situ-Created High-Affinity cis -Ligands

Senlian Hong,Chenhua Yu,Emily Rodrigues,Yujie Shi,Hongmin Chen,Peng Wang,Digantkumar G. Chapla,Tao Gao,Ruoxuan Zhuang,Kelley W. Moremen,James C. Paulson,Matthew S. Macauley,Peng Wu

DOI: https://doi.org/10.1021/acscentsci.1c00064

IF: 18.2

2021-08-13

ACS Central Science

Abstract:Sialic acid-binding immunoglobulin-like lectins, also known as Siglecs, have recently been designated as glyco-immune checkpoints. Through their interactions with sialylated glycan ligands overexpressed on tumor cells, inhibitory Siglecs on innate and adaptive immune cells modulate signaling cascades to restrain anti-tumor immune responses. However, the elucidation of the mechanisms underlying these processes is just beginning. We find that when human natural killer (NK) cells attack tumor cells, glycan remodeling occurs on the target cells at the immunological synapse. This remodeling occurs through both the transfer of sialylated glycans from NK cells to target tumor cells and the accumulation of de novo synthesized sialosides on the tumor cells. The functionalization of NK cells with a high-affinity ligand of Siglec-7 leads to multifaceted consequences in modulating a Siglec-7-regulated NK-activation. At high levels of ligand, an enzymatically added Siglec-7 ligand suppresses NK cytotoxicity through the recruitment of Siglec-7 to an immune synapse, whereas at low levels of ligand an enzymatically added Siglec-7 ligand triggers the release of Siglec-7 from the cell surface into the culture medium, preventing a Siglec-7-mediated inhibition of NK cytotoxicity. These results suggest that a glycan engineering of NK cells may provide a means to boost NK effector functions for related applications.With the formation of an immune synapse during an NK-based killing, a cancer cell upregulates its cell-surface sialylation level primarily via an accumulation of neosialylation, and its mediated immune inhibition can be blocked with a cis high-affinity ligand created chemoenzymatically, which resulted in a better tumor growth control.This article has not yet been cited by other publications.

chemistry, multidisciplinary
Proinflammatory and Cancer-Promoting Pathobiont Fusobacterium nucleatum Directly Targets Colorectal Cancer Stem Cells

Virve Cavallucci,Ivana Palucci,Marco Fidaleo,Antonella Mercuri,Letizia Masi,Valeria Emoli,Giada Bianchetti,Micol Eleonora Fiori,Gilad Bachrach,Franco Scaldaferri,Giuseppe Maulucci,Giovanni Delogu,Giovambattista Pani

DOI: https://doi.org/10.3390/biom12091256

IF: 6.064

2022-09-08

Biomolecules

Abstract:Intestinal bacterial communities participate in gut homeostasis and are recognized as crucial in bowel inflammation and colorectal cancer (CRC). Fusobacterium nucleatum (Fn), a pathobiont of the oral microflora, has recently emerged as a CRC-associated microbe linked to disease progression, metastasis, and a poor clinical outcome; however, the primary cellular and/or microenvironmental targets of this agent remain elusive. We report here that Fn directly targets putative colorectal cancer stem cells (CR-CSCs), a tumor cell subset endowed with cancer re-initiating capacity after surgery and chemotherapy. A patient-derived CSC line, highly enriched (70%) for the stem marker CD133, was expanded as tumor spheroids, dissociated, and exposed in vitro to varying amounts (range 100–500 MOI) of Fn. We found that Fn stably adheres to CSCs, likely by multiple interactions involving the tumor-associated Gal-GalNac disaccharide and the Fn-docking protein CEA-family cell adhesion molecule 1 (CEACAM-1), robustly expressed on CSCs. Importantly, Fn elicited innate immune responses in CSCs and triggered a growth factor-like, protein tyrosine phosphorylation cascade largely dependent on CEACAM-1 and culminating in the activation of p42/44 MAP kinase. Thus, the direct stimulation of CSCs by Fn may contribute to microbiota-driven colorectal carcinogenesis and represent a target for innovative therapies.

biochemistry & molecular biology
Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis

Suwen Ou,Haipeng Chen,Hufei Wang,Jinhua Ye,Huidi Liu,Yangbao Tao,Songlin Ran,Xiaoqin Mu,Fangzhou Liu,Shuang Zhu,Kangjia Luo,Zilong Guan,Yinghu Jin,Rui Huang,Yanni Song,Shu-lin Liu

DOI: https://doi.org/10.1186/s12967-023-04527-3

IF: 8.44

2023-10-09

Journal of Translational Medicine

Abstract:Abstract Background Colorectal cancer (CRC) is the third most common malignant tumor. Fusobacterium nucleatum ( F. nucleatum ) is overabundant in CRC and associated with metastasis, but the role of F. nucleatum in CRC cell migration and metastasis has not been fully elucidated. Methods Differential gene analysis, protein−protein interaction, robust rank aggregation analysis, functional enrichment analysis, and gene set variation analysis were used to figure out the potential vital genes and biological functions affected by F. nucleatum infection. The 16S rDNA sequencing and q-PCR were used to detect the abundance of F. nucleatum in tissues and stools. Then, we assessed the effect of F. nucleatum on CRC cell migration by wound healing and transwell assays, and confirmed the role of Matrix metalloproteinase 7 (MMP7) induced by F. nucleatum in cell migration. Furthermore, we dissected the mechanisms involved in F. nucleatum induced MMP7 expression. We also investigated the MMP7 expression in clinical samples and its correlation with prognosis in CRC patients. Finally, we screened out potential small molecular drugs that targeted MMP7 using the HERB database and molecular docking. Results F. nucleatum infection altered the gene expression profile and affected immune response, inflammation, biosynthesis, metabolism, adhesion and motility related biological functions in CRC. F. nucleatum was enriched in CRC and promoted the migration of CRC cell by upregulating MMP7 in vitro. MMP7 expression induced by F. nucleatum infection was mediated by the MAPK(JNK)-AP1 axis. MMP7 was highly expressed in CRC and correlated with CMS4 and poor clinical prognosis. Small molecular drugs such as δ-tocotrienol, 3,4-benzopyrene, tea polyphenols, and gallic catechin served as potential targeted therapeutic drugs for F. nucleatum induced MMP7 in CRC. Conclusions Our study showed that F. nucleatum promoted metastasis-related characteristics of CRC cell by upregulating MMP7 via MAPK(JNK)-AP1 axis. F. nucleatum and MMP7 may serve as potential therapeutic targets for repressing CRC advance and metastasis.

medicine, research & experimental

[On immunopathological phenomena in bullous pemphigoid].

Fusobacterium Nucleatum Subspecies Animalis Influences Proinflammatory Cytokine Expression and Monocyte Activation in Human Colorectal Tumors.

The adhesin RadD enhances Fusobacterium nucleatum tumour colonization and colorectal carcinogenesis

<i>Fusobacterium nucleatum</i> promotes colorectal cancer metastasis by modulating <i>KRT7-AS</i>/KRT7

Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS /KRT7.

Adhesin RadD: the secret weapon of Fusobacterium nucleatum

Association of absence of intestinal oxalate degrading bacteria with urinary calcium oxalate stone formation

Antibacterial Fusobacterium Nucleatum‐Mimicking Nanomedicine to Selectively Eliminate Tumor‐colonized Bacteria And Enhance Immunotherapy Against Colorectal Cancer

Fusobacterium nucleatum promotes inflammatory and anti-apoptotic responses in colorectal cancer cells via ADP-heptose release and ALPK1/TIFA axis activation

Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β‐catenin modulator Annexin A1

Fusobacterium nucleatum enhances the efficacy of PD-L1 blockade in colorectal cancer

Fusobacterium nucleatum induces a tumor microenvironment with diminished adaptive immunity against colorectal cancers

Impact of Fusobacterium nucleatum in the gastrointestinal tract on natural killer cells

Cell cycle‐related proteins: a flow cytofluorometric study in human tumors

Fusobacterium nucleatum promotes tumor progression in KRAS p.G12D-mutant colorectal cancer by binding to DHX15

Therapeutic Target Identification and Inhibitor Screening against Riboflavin Synthase of Colorectal Cancer Associated Fusobacterium nucleatum

Fusobacterium nucleatum infection modulates the transcriptome and epigenome of HCT116 colorectal cancer cells in an oxygen-dependent manner

Transcription Factor E2F7 Hampers the Killing Effect of NK Cells against Colorectal Cancer Cells via Activating RAD18 Transcription

Modulation of Siglec-7 Signaling Via In Situ-Created High-Affinity cis -Ligands

Proinflammatory and Cancer-Promoting Pathobiont Fusobacterium nucleatum Directly Targets Colorectal Cancer Stem Cells

Fusobacterium nucleatum upregulates MMP7 to promote metastasis-related characteristics of colorectal cancer cell via activating MAPK(JNK)-AP1 axis